Cargando…
Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498604/ http://dx.doi.org/10.1016/j.jns.2021.117795 |
| _version_ | 1784580200190705664 |
|---|---|
| author | Gallo, Antonio Capuano, Rocco Donnarumma, Giovanna Bisecco, Alvino Grimaldi, Elena Conte, Miriana D'Ambrosio, Alessandro Galdiero, Massimiliano Tedeschi, Gioacchino |
| author_facet | Gallo, Antonio Capuano, Rocco Donnarumma, Giovanna Bisecco, Alvino Grimaldi, Elena Conte, Miriana D'Ambrosio, Alessandro Galdiero, Massimiliano Tedeschi, Gioacchino |
| author_sort | Gallo, Antonio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8498604 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84986042021-10-08 Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab Gallo, Antonio Capuano, Rocco Donnarumma, Giovanna Bisecco, Alvino Grimaldi, Elena Conte, Miriana D'Ambrosio, Alessandro Galdiero, Massimiliano Tedeschi, Gioacchino J Neurol Sci Article Elsevier 2021-10 2021-10-08 /pmc/articles/PMC8498604/ http://dx.doi.org/10.1016/j.jns.2021.117795 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Gallo, Antonio Capuano, Rocco Donnarumma, Giovanna Bisecco, Alvino Grimaldi, Elena Conte, Miriana D'Ambrosio, Alessandro Galdiero, Massimiliano Tedeschi, Gioacchino Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab |
| title | Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab |
| title_full | Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab |
| title_fullStr | Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab |
| title_full_unstemmed | Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab |
| title_short | Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab |
| title_sort | preliminary evidence of blunted humoral response to sars-cov-2 (mrna) vaccine in multiple sclerosis patients treated with ocrelizumab |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498604/ http://dx.doi.org/10.1016/j.jns.2021.117795 |
| work_keys_str_mv | AT galloantonio preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab AT capuanorocco preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab AT donnarummagiovanna preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab AT biseccoalvino preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab AT grimaldielena preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab AT contemiriana preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab AT dambrosioalessandro preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab AT galdieromassimiliano preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab AT tedeschigioacchino preliminaryevidenceofbluntedhumoralresponsetosarscov2mrnavaccineinmultiplesclerosispatientstreatedwithocrelizumab |